IBDEI2ZQ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47755,0)
 ;;=D75.9^^185^2411^23
 ;;^UTILITY(U,$J,358.3,47755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47755,1,3,0)
 ;;=3^Blood/Blood-Forming Organ Disease,Unspec
 ;;^UTILITY(U,$J,358.3,47755,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,47755,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,47756,0)
 ;;=R97.1^^185^2411^26
 ;;^UTILITY(U,$J,358.3,47756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47756,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,47756,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,47756,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,47757,0)
 ;;=R97.0^^185^2411^27
 ;;^UTILITY(U,$J,358.3,47757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47757,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen
 ;;^UTILITY(U,$J,358.3,47757,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,47757,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,47758,0)
 ;;=R74.0^^185^2411^28
 ;;^UTILITY(U,$J,358.3,47758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47758,1,3,0)
 ;;=3^Elevated Liver Function Test
 ;;^UTILITY(U,$J,358.3,47758,1,4,0)
 ;;=4^R74.0
 ;;^UTILITY(U,$J,358.3,47758,2)
 ;;=^5019565
 ;;^UTILITY(U,$J,358.3,47759,0)
 ;;=D72.1^^185^2411^29
 ;;^UTILITY(U,$J,358.3,47759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47759,1,3,0)
 ;;=3^Eosinophilia
 ;;^UTILITY(U,$J,358.3,47759,1,4,0)
 ;;=4^D72.1
 ;;^UTILITY(U,$J,358.3,47759,2)
 ;;=^41173
 ;;^UTILITY(U,$J,358.3,47760,0)
 ;;=R73.09^^185^2411^30
 ;;^UTILITY(U,$J,358.3,47760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47760,1,3,0)
 ;;=3^Glucose,Abnormal (HgbA1c)
 ;;^UTILITY(U,$J,358.3,47760,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,47760,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,47761,0)
 ;;=R58.^^185^2411^31
 ;;^UTILITY(U,$J,358.3,47761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47761,1,3,0)
 ;;=3^Hemorrhage NEC
 ;;^UTILITY(U,$J,358.3,47761,1,4,0)
 ;;=4^R58.
 ;;^UTILITY(U,$J,358.3,47761,2)
 ;;=^5019528
 ;;^UTILITY(U,$J,358.3,47762,0)
 ;;=E88.09^^185^2411^32
 ;;^UTILITY(U,$J,358.3,47762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47762,1,3,0)
 ;;=3^Hypoalbuminemia NEC
 ;;^UTILITY(U,$J,358.3,47762,1,4,0)
 ;;=4^E88.09
 ;;^UTILITY(U,$J,358.3,47762,2)
 ;;=^5003027
 ;;^UTILITY(U,$J,358.3,47763,0)
 ;;=D70.9^^185^2411^33
 ;;^UTILITY(U,$J,358.3,47763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47763,1,3,0)
 ;;=3^Neutropenia,Unspec
 ;;^UTILITY(U,$J,358.3,47763,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,47763,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,47764,0)
 ;;=D72.819^^185^2411^34
 ;;^UTILITY(U,$J,358.3,47764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47764,1,3,0)
 ;;=3^White Blood Cell Count,Decreased,Unspec
 ;;^UTILITY(U,$J,358.3,47764,1,4,0)
 ;;=4^D72.819
 ;;^UTILITY(U,$J,358.3,47764,2)
 ;;=^5002376
 ;;^UTILITY(U,$J,358.3,47765,0)
 ;;=D72.829^^185^2411^35
 ;;^UTILITY(U,$J,358.3,47765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47765,1,3,0)
 ;;=3^White Blood Cell Count,Elevated,Unspec
 ;;^UTILITY(U,$J,358.3,47765,1,4,0)
 ;;=4^D72.829
 ;;^UTILITY(U,$J,358.3,47765,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,47766,0)
 ;;=D72.9^^185^2411^36
 ;;^UTILITY(U,$J,358.3,47766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47766,1,3,0)
 ;;=3^White Blood Cells Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,47766,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,47766,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,47767,0)
 ;;=L02.91^^185^2412^2
 ;;^UTILITY(U,$J,358.3,47767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47767,1,3,0)
 ;;=3^Abscess,Cutaneous,Unspec
